title: Re: Vartanian T. An examination of the results of the EVIDENCE, INCOMIN, and phase III studies of interferon beta products in the treatment of multiple sclerosis. Clin Ther. 2003;25:105-118.
authors.forename: Luca
authors.initials: L
authors.lastname: Durelli
authors.forename: Elisabetta
authors.initials: E
authors.lastname: Verdun
authors.forename: Pierangelo
authors.initials: P
authors.lastname: Barbero
authors.forename: Mauro
authors.initials: M
authors.lastname: Bergui
authors.forename: Elisabetta
authors.initials: E
authors.lastname: Versino
mesh_terms: D000367:Age Factors; D003710:Demography; D006801:Humans; D000068556:Interferon beta-1a; D016899:Interferon-beta / Q000627:therapeutic use*; D008279:Magnetic Resonance Imaging; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic; D012737:Sex Factors; D016896:Treatment Outcome
chemical_list: D016899:Interferon-beta; D000068556:Interferon beta-1a